JP2016525560A5 - - Google Patents

Download PDF

Info

Publication number
JP2016525560A5
JP2016525560A5 JP2016530509A JP2016530509A JP2016525560A5 JP 2016525560 A5 JP2016525560 A5 JP 2016525560A5 JP 2016530509 A JP2016530509 A JP 2016530509A JP 2016530509 A JP2016530509 A JP 2016530509A JP 2016525560 A5 JP2016525560 A5 JP 2016525560A5
Authority
JP
Japan
Prior art keywords
conjugate
seq
use according
sequence
cell binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2016530509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016525560A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/066345 external-priority patent/WO2015014879A1/en
Publication of JP2016525560A publication Critical patent/JP2016525560A/ja
Publication of JP2016525560A5 publication Critical patent/JP2016525560A5/ja
Abandoned legal-status Critical Current

Links

JP2016530509A 2013-08-02 2014-07-30 固形腫瘍を処置するための抗−Muc1メイタンシノイドイムノコンジュゲート抗体の使用 Abandoned JP2016525560A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13306119 2013-08-02
EP13306119.2 2013-08-02
PCT/EP2014/066345 WO2015014879A1 (en) 2013-08-02 2014-07-30 Use of anti-muc1 maytansinoid immunoconjugate antibody for the treatment of solid tumors

Publications (2)

Publication Number Publication Date
JP2016525560A JP2016525560A (ja) 2016-08-25
JP2016525560A5 true JP2016525560A5 (https=) 2017-07-13

Family

ID=49036539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016530509A Abandoned JP2016525560A (ja) 2013-08-02 2014-07-30 固形腫瘍を処置するための抗−Muc1メイタンシノイドイムノコンジュゲート抗体の使用

Country Status (12)

Country Link
US (1) US20160347856A1 (https=)
EP (1) EP3027218A1 (https=)
JP (1) JP2016525560A (https=)
KR (1) KR20160035600A (https=)
CN (1) CN105592861A (https=)
AU (1) AU2014298514A1 (https=)
CA (1) CA2919932A1 (https=)
EA (1) EA201690321A1 (https=)
IL (1) IL243843A0 (https=)
MX (1) MX2016001541A (https=)
TW (1) TW201605479A (https=)
WO (1) WO2015014879A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106999604B (zh) * 2014-09-02 2021-08-03 伊缪诺金公司 用于配制抗体药物缀合物组合物的方法
GB201506388D0 (en) * 2015-04-15 2015-05-27 Berkel Patricius H C Van And Cancer Res Technology Ltd And Howard Philip W Site-specific antibody-drug conjugates
TW201808336A (zh) 2016-05-11 2018-03-16 賽諾菲公司 用抗muc1類美登素免疫綴合物抗體治療腫瘤的治療方案
CN105997942B (zh) * 2016-06-24 2019-01-29 浙江大学 一种人血清白蛋白负载美登素类药物的纳米颗粒及其制备方法和应用
CN112105384B (zh) * 2017-01-18 2024-08-23 苏州启航纳米药物有限公司 癌糖肽的单克隆和人源化抗体
WO2019030284A1 (en) * 2017-08-09 2019-02-14 Helmholtz-Zentrum für Infektionsforschung GmbH NOVEL TARGETED CYTOTOXIC RATJADONE DERIVATIVES AND CONJUGATES THEREOF
HUE067382T2 (hu) 2018-05-18 2024-10-28 Daiichi Sankyo Co Ltd Anti-MUC1-exatecan antitest-hatóanyag konjugátum
MX2021005116A (es) * 2018-11-02 2021-07-15 Cytomx Therapeutics Inc Anticuerpos activables anti-cd166 y metodos de uso de estos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321704A1 (en) * 1998-02-25 1999-09-02 Takeo Omura Remedies for corneal epithelium disturbance
EA014640B1 (ru) * 2003-07-21 2010-12-30 Иммьюноджен, Инк. Антитело или его эпитоп-связывающий фрагмент, которые связываются с гликотопом са6, и способы их применения
MX2008002607A (es) * 2005-08-22 2008-03-19 Immunogen Inc Un conjugado citotoxico ca6 antigeno-especifico y metodos para utilizar el mismo.
WO2010126552A1 (en) * 2009-04-30 2010-11-04 Immunogen, Inc. Potent cell-binding agent drug conjugates
EP2486023A4 (en) * 2009-10-06 2014-05-07 Immunogen Inc EFFICIENT CONJUGATES AND HYDROPHILIC BINDER

Similar Documents

Publication Publication Date Title
JP2016525560A5 (https=)
JP7425026B2 (ja) フタロシアニン色素コンジュゲートおよびその保存法
JP2024522312A (ja) 抗体薬物複合体の調製方法および使用
ES2992591T3 (en) Compositions, combinations and related methods for photoimmunotherapy
JP7585230B2 (ja) バイパラトピックFR-α抗体及びイムノコンジュゲート
CN106999604B (zh) 用于配制抗体药物缀合物组合物的方法
RU2016129894A (ru) Ковалентно связанные конъюгаты хеликар-антитело против хеликара и их применения
JP2014515036A5 (https=)
JP2016502504A5 (https=)
JP2020508323A (ja) 光免疫療法のための治療用組成物および関連する方法
JP2016531915A5 (https=)
JP2017535246A5 (https=)
JP2015534580A5 (https=)
JP7458998B2 (ja) フタロシアニン色素コンジュゲート組成物
RU2018111205A (ru) Терапевтические комбинации, содержащие анти-folr1 иммуноконъюгаты
HRP20240917T1 (hr) Režimi doziranja anti-folr1 imunokonjugata
CA2858133A1 (en) Uses of immunoconjugates targeting cd138
TW201919711A (zh) 預防免疫結合物中之甲硫胺酸氧化之方法
KR102544135B1 (ko) c-Kit을 표적으로 하는 면역접합체
WO2024213081A1 (zh) 抗体药物偶联物在制备预防和/或治疗癌症的药物中的用途
CN121240889A (zh) 抗体药物缀合物
HK40048277A (en) Phthalocyanine dye conjugates and their storage
BR112019027448B1 (pt) Imunoconjugado compreendendo um anticorpo conjugado a uma porção de fármaco citotóxica, composição farmacêutica e uso dos mesmos
WO2018174005A1 (ja) 医薬